Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation

Acta Biomater. 2012 May;8(5):1768-77. doi: 10.1016/j.actbio.2012.01.009. Epub 2012 Jan 18.

Abstract

The purpose of this study was to develop and characterize a chitosan gel/gelatin microsphere (MSs) dual delivery system for sequential release of bone morphogenetic protein-2 (BMP-2) and insulin-like growth factor-1 (IGF-1) to enhance osteoblast differentiation in vitro. We made and characterized the delivery system based on its degree of cross-linking, degradation, and release kinetics. We also evaluated the cytotoxicity of the delivery system and the effect of growth factors on cell response using pre-osteoblast W-20-17 mouse bone marrow stromal cells. IGF-1 was first loaded into MSs, and then the IGF-1-containing MSs were encapsulated into the chitosan gel which contained BMP-2. Cross-linking of gelatin with glyoxal via Schiff bases significantly increased thermal stability and decreased the solubility of the MSs, leading to a significant decrease in the initial release of IGF-1. Encapsulation of the MSs into the chitosan gel generated polyelectrolyte complexes by intermolecular interactions, which further affected the release kinetics of IGF-1. This combinational delivery system provided an initial release of BMP-2 followed by a slow and sustained release of IGF-1. Significantly greater alkaline phosphatase activity was found in W-20-17 cells treated with the sequential delivery system compared with other treatments (P<0.05) after a week of culture.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2 / administration & dosage*
  • Bone Morphogenetic Protein 2 / chemistry
  • Capsules / chemistry
  • Cell Differentiation / drug effects
  • Cell Line
  • Chitosan / chemistry*
  • Delayed-Action Preparations / chemical synthesis
  • Delayed-Action Preparations / pharmacology*
  • Gelatin / chemistry*
  • Gels / chemistry
  • Insulin-Like Growth Factor I / administration & dosage*
  • Insulin-Like Growth Factor I / chemistry
  • Materials Testing
  • Mice
  • Osteoblasts / cytology*
  • Osteoblasts / drug effects
  • Tissue Engineering / methods*

Substances

  • Bmp2 protein, mouse
  • Bone Morphogenetic Protein 2
  • Capsules
  • Delayed-Action Preparations
  • Gels
  • insulin-like growth factor-1, mouse
  • Insulin-Like Growth Factor I
  • Gelatin
  • Chitosan